[vc_row inner_container=»true» bg_color=»#ffffff» style=»margin-bottom:0px; padding-bottom:0px;»][vc_column alignment=»left» width=»1/2″]

Carboxil Syrup

[/vc_column][vc_column width=»1/2″][/vc_column][/vc_row][vc_row inner_container=»true» bg_color=»#ffffff» style=»margin-top:0px; margin-bottom:0px;»][vc_column width=»1/1″]


Carboxil Syrup represents a rational combination of two substances with a complementary effect: Carboxymethylcysteine ​​and Sobrerol.

Carboxymethylcysteine ​​is a mucolytic with a fast and intense fluidizing effect on viscous airway secretions, especially the mucous or mucopurulent type.

Sobrerol, in addition to potentiating the mucolytic action of Carboxymethylcysteine, induces a removal of secretions, cleaning the airways.

Likewise, Carboxil causes, on the one hand, the reduction of pathological viscosities of mucus in the respiratory tract, and on the other hand, its removal. In this way, Carboxil allows a better regeneration of the altered respiratory mucosa, through a global process, that is, mucolytic, mucorregulatory and expectorant.

Therapeutic indications

  • Fluidizing treatment of mucous and mucopurulent secretions in acute and chronic conditions of the respiratory system: bronchitis, bronchiectasis, bronchopneumonia, especially associated with respiratory failure (asthma, emphysema); Bronchonic catarrh associated with forms of pulmonary tuberculosis and pneumonia, rhinopharyngitis, laryngotracheitis.
  • Prophylaxis and treatment of bronchopulmonary complications in surgical interventions.

Drug interactions

No pharmacological interactions with the components of Carboxil Syrup are found.

There is no contraindication in the administration of Carboxil Syrup during the period of pregnancy and lactation.

Carboxil Syrup has no effect on the ability to drive and use machines.

[/vc_column][/vc_row][vc_row inner_container=»true» bg_color=»#ffffff» style=»margin-top:0px; margin-bottom:0px;»][vc_column width=»1/2″]


  • Individual hypersensitivity to each of the components of Carboxil Syrup.
  • Peptic ulcer in active phase.

Side effects

In the indicated dosage, Carboxil Syrup is generally well tolerated by infants and children and adults. The administration of high doses, higher than the recommended ones, can cause digestive disorders such as gastralgia, nausea and diarrhea.

Special precautions for use

Carboxil Syrup does not require any special precautions for its administration.



For children under 5 years: 5 ml 2 times a day.

For children from 5 to 10 years old: 10 ml 2 times a day.

For adults: 10 ml 3 times a day.

[/vc_column][vc_column width=»1/2″ style=»background-color:#f4f4f4; height:100%; padding-left:10px; padding-right:10px;»]


Each 5 ml of syrup contains:

Carboxymethylcysteine    250 mg

Sobrerol     40 mg

Administration route



Box containing a bottle with 120 ml of syrup.

M/M Box containing bottle with 30 ml of syrup.

Storage Recommendations

Store below 30 °C.


Scroll al inicio